) The Genetics/Genomics Core is organized to provide both consultation and state-of-the-art technologies and data interpretation in genomics and bioinformatics. Core scientists interact with CCC researchers at the design phase of projects and assist in incorporating genomics approaches by a) generation of preliminary data, b) writing methodologies, c) high throughput implementation of technology, and d) data mining in public and proprietary databases. The Core supports research investigating genetic elements responsible for cancer susceptibility and genetic factors involved in neoplastic initiation and progression. Existing Core technologies include: 1) high-throughput DNA sequencing and genotyping (ABI 3700); 2) real-time quantitative PCR for mRNA and/or DNA (ABI 7700); 3) high-volume microsatellite-repeat genotyping (ABI 377s) and SNP analysis (ABI TaqMan7700); 4) rapid, inexpensive 96-well-based polymorphism/mutation hunting with HPLC heteroduplexing (WAVE); 5) 24-fluor color SKY painting of chromosomes; 6) FISH gene mapping to chromosomes; 7) Comparative Genome Hybridization (CGH); and 8) high throughput robotic assistance in picking and arraying clones, growing large library collections, and general liquid handling; 9) single cell micromanipulation and molecular/cytogenetics; and 10) gene expression profiling using in-house microprinted glass microarrays of the entire (up-to-date UNIGENE) human and rat EST collections. The facility is Certified by federal (CLIA-88), state (DoH), and professional societies (ASHG and CAP) for data integrity. Bioinformatics is a critical component of any genomics and proteomics facility and the Core operates, in partnership with PE-Informatics, software for a) sample acquisition and tracking, correlation with clinical information, work assignment, clone/plate management and raw data reporting (SQL*LIMS & SQL*GT); b) data mining tools (extensive software); and c) systems microarray and sequence analysis (GeneKeeper) and sophisticated publish/subscribe/share capability throughout the CCC (BioMerge). The Core has onsite, a 40-gigabite database of sequence data accessible with these software tools, a UNIX based SGI supercomputer and multiple SUN workstations linked to researchers via a GigaPoP fiber backbone. Bioinformatics personnel include an OS system manager, Oracle databasers, application specialists, and technology-specific project managers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA022453-22S1
Application #
6503919
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-09-27
Project End
2001-11-30
Budget Start
Budget End
Support Year
22
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Kraniak, Janice M; Chalasani, Anita; Wallace, Margaret R et al. (2018) Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening. Exp Neurol 299:289-298
An, Myunggi; Yu, Chunsong; Xi, Jingchao et al. (2018) Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity. Nanoscale 10:9311-9319
Neslund-Dudas, Christine M; McBride, Russell B; Kandegedara, Ashoka et al. (2018) Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men. J Trace Elem Med Biol 48:233-238
Wu, Jheng-Yu; Xiang, Shengyan; Zhang, Mu et al. (2018) Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity. J Biol Chem 293:1976-1993
Negmeldin, Ahmed T; Knoff, Joseph R; Pflum, Mary Kay H (2018) The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity. Eur J Med Chem 143:1790-1806
Tamura, Koji; Yu, Jun; Hata, Tatsuo et al. (2018) Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer. Proc Natl Acad Sci U S A 115:4767-4772
Matherly, Larry H; Hou, Zhanjun; Gangjee, Aleem (2018) The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer. Cancer Chemother Pharmacol 81:1-15
Pollack, Murray M; Holubkov, Richard; Reeder, Ron et al. (2018) PICU Length of Stay: Factors Associated With Bed Utilization and Development of a Benchmarking Model. Pediatr Crit Care Med 19:196-203
Bao, Xun; Wu, Jianmei; Sanai, Nader et al. (2018) A liquid chromatography with tandem mass spectrometry method for quantitating total and unbound ceritinib in patient plasma and brain tumor. J Pharm Anal 8:20-26
Heath, Elisabeth I; Lynce, Filipa; Xiu, Joanne et al. (2018) Racial Disparities in the Molecular Landscape of Cancer. Anticancer Res 38:2235-2240

Showing the most recent 10 out of 826 publications